Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion type Assertion NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_head.
- NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion description "[Medullary thyroid cancer (MTC) is frequently associated with mutations in the tyrosine kinase Ret and with increased expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_provenance.
- NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion evidence source_evidence_literature NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_provenance.
- NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion SIO_000772 21422803 NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_provenance.
- NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion wasDerivedFrom befree-2016 NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_provenance.
- NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_assertion wasGeneratedBy ECO_0000203 NP881063.RA450EbAyoZJQZMcXtjeMI92Bv-yMxCNSVyHevS0c3V_g130_provenance.